Accueil   Diary - News   All news Inovotion

Inovotion

INOVOTION: New generation of in vivo efficacy and toxicity tests – accelerate your preclinical trials

 

INOVOTION offers a new generation of in vivo efficacy and toxicity tests, fast, sensitive, reliable and affordable, based on human cancer cell lines in chick egg embryo. They are intended for chemists and biologists in drug discovery and insert before mouse tests to eliminate more early the low value molecules. They improve the productivity of R&D process.

 

 

INOVOTION currently provides three types of in vivo tests:

 

  • Efficacy and toxicity in oncology
  • Target validation in oncology
  • Toxicity for drug candidates

 

These unique tests have multiple advantages:

 

  • Fast: only 1 month to obtain results
  • Sensitive: need minute amount of test compound (1000 times less)
  • Reliable: strong statistical results
  • Affordable: 5 to 10 times less expensive in comparison to equivalent in vivo model
  • Predictivity: equivalent to other preclinical models to predict efficacy and toxicity on human
  • In vivo without animal testing

 

> 5 years of research: a technology already rewarded

 

This technology is born at l'Institut Albert Bonniot (IAB - CRI INSERM/UJF U823). Five years of R&D on « In Ovo » project for the team of Prof. Jean Viallet allowed to develop this new approach, rewarded in 2014 by the prestigious label i-Lab (section CréaDev).

 

> Customers in Europe and worldwide

 

These tests have already been marketed, biotech pharma, institute and research center involved in oncology in Europe and worldwide. Several contacts formarketing are engaged with several universities and big-pharma in USA. INOVOTION participates to H2020 grants.

 

> Company development

 

INOVOTION extends its activities with important R&D investments and participates to consortiums in order to answer to grant obtaining in French and Europe.

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree